Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	-0.33%	+1.83%	+23.03%	-6.22%	68.85B
UCB	+0.67%	+0.93%	+37.53%	+198.53%	52.13B
SAMSUNG BIOLOGICS CO.,LTD.	+0.94%	+39.60%	+39.60%	+39.60%	43.46B
CSL LIMITED	+1.12%	+0.35%	-50.35%	-52.35%	41.24B
BIOGEN INC.	-1.40%	+3.43%	+60.07%	-26.01%	30.41B
MODERNA, INC.	-2.11%	-9.45%	+91.99%	-49.58%	24.53B
INCYTE CORPORATION	+0.51%	+0.46%	+70.08%	+91.96%	23.42B
INNOVENT BIOLOGICS, INC.	-5.57%	-0.84%	-0.17%	+174.11%	19.75B
SWEDISH ORPHAN BIOVITRUM AB	-0.86%	-1.99%	+68.42%	+124.39%	16.57B
Average	-0.70%	-0.81%	+37.80%	+54.94%	35.6B
Weighted average by Cap.	-0.34%	-0.07%	+31.34%	+47.23%